Immune-checkpoint inhibitors: long-term implications of toxicity | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma - ScienceDirect
Nanoparticle-Based Immunotherapy for Cancer | ACS Nano
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Frontiers | Research progress in inducing immunogenic cell death of tumor cells
T follicular helper cells in cancer: Trends in Cancer
Systemic immunity in cancer | Nature Reviews Cancer
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research
The Contribution of Epigenetics to Cancer Immunotherapy: Trends in Immunology
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Frontiers | Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy
What Are Immune Checkpoints?
IJMS | Free Full-Text | Autoimmune Responses in Oncology: Causes and Significance
Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response | ACS Nano
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Current Oncology | Free Full-Text | Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Elevated tumor markers for monitoring tumor response to immunotherapy - ScienceDirect
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
